scout
|Videos|November 15, 2017

An Overview of an Immuno-Oncology Panel for Standardized Profiling of Immune Status

Author(s)Ralf Huss, MD

Ralf Huss, MD, Chief Medical Officer of Definiens, discusses a new immuno-oncology panel introduced by Definiens during the The Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting. The goal of the panel is to standardize the immunoprofiling of tumors to better predict response to immuno-oncology treatment.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME